Development of a predictive radiomics signature for response to immune checkpoint inhibitors (ICIs) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN)
暂无分享,去创建一个
L. Siu | A. Hansen | R. Jang | U. Metser | A. Prawira | E. Chen | P. Dufort | A. Spreafico | A. Razak | J. Halankar | D. Paravasthu